121 related articles for article (PubMed ID: 16159600)
1. A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity.
Kontush A; de Faria EC; Chantepie S; Chapman MJ
Atherosclerosis; 2005 Oct; 182(2):277-85. PubMed ID: 16159600
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity.
Hansel B; Giral P; Nobecourt E; Chantepie S; Bruckert E; Chapman MJ; Kontush A
J Clin Endocrinol Metab; 2004 Oct; 89(10):4963-71. PubMed ID: 15472192
[TBL] [Abstract][Full Text] [Related]
3. Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties.
Kontush A; de Faria EC; Chantepie S; Chapman MJ
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):526-33. PubMed ID: 14739123
[TBL] [Abstract][Full Text] [Related]
4. Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia.
Nobécourt E; Jacqueminet S; Hansel B; Chantepie S; Grimaldi A; Chapman MJ; Kontush A
Diabetologia; 2005 Mar; 48(3):529-38. PubMed ID: 15729582
[TBL] [Abstract][Full Text] [Related]
5. Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis.
Hussein H; Saheb S; Couturier M; Atassi M; Orsoni A; Carrié A; Therond P; Chantepie S; Robillard P; Bruckert E; Chapman MJ; Kontush A
J Clin Lipidol; 2016; 10(1):124-33. PubMed ID: 26892129
[TBL] [Abstract][Full Text] [Related]
6. Lifestyle intervention enhances high-density lipoprotein function among patients with metabolic syndrome only at normal low-density lipoprotein cholesterol plasma levels.
Hansel B; Bonnefont-Rousselot D; Orsoni A; Bittar R; Giral P; Roussel R; Marre M; Mohammedi K; Bruckert E; Chapman MJ; Kontush A
J Clin Lipidol; 2016; 10(5):1172-81. PubMed ID: 27678434
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity.
de Souza JA; Vindis C; Hansel B; Nègre-Salvayre A; Therond P; Serrano CV; Chantepie S; Salvayre R; Bruckert E; Chapman MJ; Kontush A
Atherosclerosis; 2008 Mar; 197(1):84-94. PubMed ID: 17868679
[TBL] [Abstract][Full Text] [Related]
8. Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects.
Vekic J; Kotur-Stevuljevic J; Jelic-Ivanovic Z; Spasic S; Spasojevic-Kalimanovska V; Topic A; Zeljkovic A; Stefanovic A; Zunic G
Eur J Clin Invest; 2007 Sep; 37(9):715-23. PubMed ID: 17696961
[TBL] [Abstract][Full Text] [Related]
9. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress.
Kontush A; Chantepie S; Chapman MJ
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1881-8. PubMed ID: 12920049
[TBL] [Abstract][Full Text] [Related]
10. Skew of plasma low- and high-density lipoprotein distributions to less dense subfractions in normotriglyceridemic chronic kidney disease patients on maintenance hemodialysis treatment.
Homma K; Homma Y; Shiina Y; Wakino S; Suzuki M; Fujishima S; Hayashi K; Hori S; Itoh H
Nephron Clin Pract; 2013; 123(1-2):41-5. PubMed ID: 23752220
[TBL] [Abstract][Full Text] [Related]
11. Altered lipidome and antioxidative activity of small, dense HDL in normolipidemic rheumatoid arthritis: relevance of inflammation.
Gómez Rosso L; Lhomme M; Meroño T; Sorroche P; Catoggio L; Soriano E; Saucedo C; Malah V; Dauteuille C; Boero L; Lesnik P; Robillard P; John Chapman M; Brites F; Kontush A
Atherosclerosis; 2014 Dec; 237(2):652-60. PubMed ID: 25463101
[TBL] [Abstract][Full Text] [Related]
12. Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities.
Kontush A; Therond P; Zerrad A; Couturier M; Négre-Salvayre A; de Souza JA; Chantepie S; Chapman MJ
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1843-9. PubMed ID: 17569880
[TBL] [Abstract][Full Text] [Related]
13. Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities.
Camont L; Lhomme M; Rached F; Le Goff W; Nègre-Salvayre A; Salvayre R; Calzada C; Lagarde M; Chapman MJ; Kontush A
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2715-23. PubMed ID: 24092747
[TBL] [Abstract][Full Text] [Related]
14. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.
Kontush A; Chapman MJ
Pharmacol Rev; 2006 Sep; 58(3):342-74. PubMed ID: 16968945
[TBL] [Abstract][Full Text] [Related]
15. High-density lipoprotein subclasses distribution and composition in Mexican adolescents with low HDL cholesterol and/or high triglyceride concentrations, and its association with insulin and C-reactive protein.
Medina-Urrutia A; Juarez-Rojas JG; Martínez-Alvarado R; Jorge-Galarza E; Posadas-Sánchez R; Cardoso-Saldaña G; Caracas-Portilla N; Mendoza-Perez E; Posadas-Romero C
Atherosclerosis; 2008 Dec; 201(2):392-7. PubMed ID: 18420210
[TBL] [Abstract][Full Text] [Related]
16. Elevated HDL2-paraoxonase and reduced CETP activity are associated with a dramatically lower ratio of LDL-cholesterol/total cholesterol in a hypercholesterolemic and hypertriglyceridemic patient.
Lee JH; Park JH; Lee SH; Kim JR; Cho KH
Int J Mol Med; 2010 Jun; 25(6):945-51. PubMed ID: 20428800
[TBL] [Abstract][Full Text] [Related]
17. Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: Relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A.
Rached F; Lhomme M; Camont L; Gomes F; Dauteuille C; Robillard P; Santos RD; Lesnik P; Serrano CV; Chapman MJ; Kontush A
Biochim Biophys Acta; 2015 Sep; 1851(9):1254-61. PubMed ID: 26037829
[TBL] [Abstract][Full Text] [Related]
18. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.
Oravec S; Dostal E; Dukát A; Gavorník P; Kucera M; Gruber K
Neuro Endocrinol Lett; 2011; 32(4):502-9. PubMed ID: 21876506
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein profile in patients who survive a stroke.
Oravec S; Krivosikova Z; Krivosik M; Gruber K; Gruber M; Dukát A; Gavorník P
Neuro Endocrinol Lett; 2011; 32(4):496-501. PubMed ID: 21876499
[TBL] [Abstract][Full Text] [Related]
20. HDL subspecies in young adult twins: heritability and impact of overweight.
Pietiläinen KH; Söderlund S; Rissanen A; Nakanishi S; Jauhiainen M; Taskinen MR; Kaprio J
Obesity (Silver Spring); 2009 Jun; 17(6):1208-14. PubMed ID: 19584879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
